Zio XT ECG Monitoring System vs ClearRead CT
AI Verdict
Choose Zio XT ECG Monitoring System if…
Choose Zio XT ECG Monitoring System if you need extended, continuous cardiac monitoring for patients where intermittent arrhythmias are suspected or have been difficult to capture with shorter monitoring periods. Its wearable, lead-free design ensures high patient compliance and comfort for up to 14 days, making it ideal for detecting elusive cardiac events in a patient's natural environment.
View Zio XT ECG Monitoring System →Choose ClearRead CT if…
Choose ClearRead CT if your radiology practice requires an AI-powered solution to enhance the detection and characterization of pulmonary nodules and to perform coronary artery calcification scoring from CT scans. This tool is particularly well-suited for improving diagnostic accuracy, reducing reading times, and streamlining workflows in high-volume imaging environments, aiding in early disease detection and risk assessment.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio XT ECG Monitoring System | ClearRead CT |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware required. | On-premise (stand-alone server, virtual machine) and Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemTool A (Zio XT) excels in patient-centric usability, featuring a comfortable, wire-free, water-resistant wearable design that leads to high patient compliance and satisfaction. Patients report it is easy to use and unobtrusive, with 98% compliance and 88% finding it easy to use. While Tool B focuses on radiologist workflow efficiency, Tool A's direct impact on the end-user (patient) experience for continuous monitoring is a broader measure of usability.
Clinical Value
ClearRead CTBoth tools offer significant clinical value and are FDA-cleared. Tool B (ClearRead CT) provides quantifiable improvements in diagnostic accuracy, with a 29% reduction in missed actionable pulmonary nodules and a 36% reduction in reading times for CT scans. It also demonstrates high agreement for coronary artery calcification scoring. Tool A shows high diagnostic yield for arrhythmias, but Tool B's specific metrics for improved detection and efficiency in critical diagnostic tasks give it a slight edge.
Pricing & Value
Zio XT ECG Monitoring SystemTool A (Zio XT) offers transparent pricing details, providing specific costs per patient for both the UK (u00a3310) and US Medicare rates (approximately $229-$260.35). This clarity allows healthcare providers to readily assess its value proposition. Tool B (ClearRead CT) only states 'contact for pricing,' making a direct comparison and value assessment impossible without further inquiry.
Enterprise Readiness
ClearRead CTTool B (ClearRead CT) offers superior deployment flexibility with both on-premise and cloud options, catering to diverse enterprise IT infrastructures. It emphasizes seamless PACS integration and vendor-neutral processing, which are critical for radiology departments. Additionally, its ISO27001 certification underscores a robust security and operational framework for enterprise environments.
Innovation
ClearRead CTBoth tools leverage AI innovatively. However, Tool B (ClearRead CT) stands out with its patented vessel suppression technology (Clear Visual Intelligence), which significantly enhances the visibility of pulmonary nodules in complex CT images. This advanced image processing, combined with automated nodule tracking and CAC scoring, represents a distinct and impactful innovation in medical imaging analysis.
Support & Docs
ClearRead CTTool B (ClearRead CT) provides a comprehensive support framework, including customer care via phone and email, a dedicated support portal with FAQs, series recommendations, system requirements, and workflows. While both offer documentation, Tool B's structured resources and its ISO27001 certification suggest a more formalized and potentially higher standard of support and documentation processes.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio XT ECG Monitoring System | ClearRead CT |
|---|---|---|
| Primary Function | Wearable, single-lead ECG biosensor for continuous cardiac monitoring and arrhythmia detection. | FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| Company | iRhythm Technologies | RIVERAIN TECHNOLOGIES |
| Target Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Pulmonology, Radiology |
| Core Technology/Methodology | Wearable single-lead ECG biosensor (Zio biosensor) with proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis. | Advanced AI and patented Vessel Suppression (Clear Visual Intelligence) for CT scan analysis. |
| Specific Clinical Applications | Continuous ambulatory cardiac monitoring for up to 14 days, arrhythmia detection, patient-activated event logging. | Pulmonary Nodule Detection (solid, part-solid, ground glass), Nodule Characterization and Measurement, Automated Nodule Tracking and Comparison, Coronary Artery Calcification (CAC) Scoring. |
Videos
Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and ClearRead CT.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio XT ECG Monitoring System or ClearRead CT
Backers
Who funded each tool's parent company.